Journal
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS
Volume 29, Issue 3, Pages 141-148Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.arteri.2016.06.003
Keywords
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Cardiovascular risk; Cardiovascular diseases; Atherosclerosis; Treatment
Categories
Ask authors/readers for more resources
Non-alcoholic fatty liver disease (NAFLD) comprises a series of histologically lesions similar to those induced by alcohol consumption in people with very little or no liver damage. The importance of NAFLD is its high prevalence in the Western world and, from the point of view of the liver, in its gradual progression from steatosis to steatohepatitis, cirrhosis, and liver cancer. During the last decade it has been observed that NAFLD leads to an increased cardiovascular risk with acceleration of arteriosclerosis and events related to it, being the main cause of its morbidity and mortality. This review, updated to January 2016, consists of two parts, with the first part analysing the association of NAFLD with cardiovascular disease. (C) 2016 Sociedad Espanola de Arteriosclerosis. Published by Elsevier Espana, S.L.U. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available